732936001: Tablet (unit of presentation)

SNOMED CT Concept\Qualifier value\Unit of measure\Unit of presentation\Tablet

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3498397012 Tablet en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tablet	Is a	Unit of presentation	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely imatinib (as imatinib mesilate) 400 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely levothyroxine sodium anhydrous 100 microgram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely levothyroxine sodium anhydrous 100 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely lofepramine (as lofepramine hydrochloride) 70 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely lofepramine (as lofepramine hydrochloride) 70 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely quinagolide (as quinagolide hydrochloride) 75 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely quinagolide (as quinagolide hydrochloride) 75 microgram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely ibandronic acid (as ibandronate sodium monohydrate) 50 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely pergolide (as pergolide mesilate) 250 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely pergolide (as pergolide mesilate) 250 microgram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely quetiapine (as quetiapine fumarate) 150 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely reboxetine (as reboxetine mesilate) 4 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely reboxetine (as reboxetine mesilate) 4 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely darunavir (as darunavir ethanolate) 400 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely darunavir (as darunavir ethanolate) 600 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely darunavir (as darunavir ethanolate) 600 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely atorvastatin (as atorvastatin calcium trihydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely darunavir (as darunavir ethanolate) 300 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely fenoprofen (as fenoprofen calcium) 300 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely fenoprofen (as fenoprofen calcium) 300 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely levothyroxine sodium anhydrous 50 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	True	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely levothyroxine sodium anhydrous 50 microgram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	2
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator unit	False	Tablet	Inferred relationship	Existential restriction modifier	1
Product containing precisely tiagabine (as tiagabine hydrochloride monohydrate) 15 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	False	Tablet	Inferred relationship	Existential restriction modifier
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	True	Tablet	Inferred relationship	Existential restriction modifier

Start Previous Page 57 of 153 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3498396015	Tablet (unit of presentation)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3498397012	Tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module